The Latest Research on CyberKnife Radiation Therapy
4 New Scientific Studies Confirm the Safety & Effectiveness of CyberKnife for Prostate, Lung, Head & Neck Cancers
The 58th Annual American Society for Radiation Oncology (ASTRO) meeting was just held in Boston and most important to us at the CyberKnife Center of Miami was the presentation of four new studies concerning the use of CyberKnife Radiation Therapy.
The mounting research further validates the use of Stereotactic Body Radiation Therapy (SBRT) taking this technology closer to becoming the gold standard in radiation treatment.
The studies prove the safety, effectiveness and lifesaving benefits of CyberKnife for Prostate, Lung, Head & Neck Cancers.
We have compiled links to the studies here for your easy viewing:
ASTRO Study #2: For men with early-stage, low-risk prostate cancer, treatment with CyberKnife (SBRT) offers comparable health-related quality-of-life outcomes in 1/3rd less treatment time than conventional radiation
ASTRO Study #3: Widespread use of CyberKnife has increased survival rates for elderly patients who received CyberKnife Treatments for early-stage non–small cell lung cancer from roughly 40% to 60% over the past decade
Talk to one of our cancer experts at the CyberKnife Center of Miami to see if CyberKnife Therapy is a good treatment choice for you or a loved one – 305-279-2900